Delivery Order SPE2DB20D3303-SPE2DB26FY1C8
- Not listed
- The Defense Logistics Agency awarded a $4,870.56 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with completion scheduled for September 16, 2025. This delivery order is a child...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $2,532.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a standard pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $42,827.06 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with a contract ceiling value of $4,217.23. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $3,824.58 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12 gram units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $1,788.90 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Fluticasone Propionate HFA 110 microgram inhalers (12-gram units). This competitive, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $1,184.52, with an ultimate completion date of August 4, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,404.80 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 mcg inhalers (10.6 grams) on September 18, 2025, with completion targeted for September 19, 2025. This non-competitive delivery order represents a firm fixed-price transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location....
- The Defense Logistics Agency Medical Supply Chain awarded a $26,397.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams) on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY1C8Delivery Order
The Defense Logistics Agency awarded a $1,566.94 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Fluticasone Propionate HFA 44 mcg inhalers (10.6 grams). This firm fixed-price delivery order, with completion scheduled for October 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, holds a comprehensive $999.999 billion IDC with DLA Troop Support Medical running through December 2026, which serves as the vehicle enabling this and other pharmaceutical deliveries. AmerisourceBergen's extensive contract portfolio with DLA demonstrates the company's established capability to supply diverse pharmaceutical products and medical commodities to support military and veteran healthcare systems. The vendor's federal procurement track record reflects consistent delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for the corticosteroid inhalant represents a routine pharmaceutical supply fulfillment typical of the company's ongoing support to the Defense Health Agency and other federal healthcare entities through its prime vendor global program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/22/25 |